Your session is about to expire
← Back to Search
rTMS for Gulf War Syndrome
Study Summary
This trial will test if rTMS can help relieve symptoms of Gulf War Illness, a condition that causes pain and other co-morbid symptoms.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- The Kansas Criteria for Gulf War Veterans' Illness (GWI) will be used to determine if you are eligible for the study.I am currently receiving therapy for my memory/thinking or PTSD.I am under 65 and served in the Persian Gulf War region for at least 30 days.I suffer from chronic tension or cluster headaches.I experience severe headaches weekly that last more than an hour.My daily muscle pain is more than 3 on a scale of 0 to 10.My daily joint pain in my arms or legs averages more than 3 out of 10.I understand the study and can communicate in English.I have low back pain due to a nerve or joint problem.You have been diagnosed with migraine headaches without any warning signs (aura) according to the guidelines of the International Headache Society.My daily muscle pain is more than 3 on a scale of 0 to 10.I am under 65 and served in the Persian Gulf War region for at least 30 days.I do not have a history of dementia, major psychiatric diseases, or life-threatening diseases.My daily joint pain in my arms or legs averages more than 3 out of 10.I have chronic nerve pain like CRPS or painful neuropathy.I experience severe headaches weekly that last more than an hour.I have had seizures in the past.You meet the criteria set by the Centers for Disease Control and Prevention (CDC) for Gulf War illness (GWI).
- Group 1: Active rTMS at the LDLPFC
- Group 2: Sham rTMS at the LDLPFC
- Group 3: Active rTMS at the LMC
- Group 4: Sham rTMS at the LMC
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Who is eligible to be involved in this research experiment?
"This trial is currently seeking 80 individuals suffering from depression aged between 18 and 65. To qualify, participants must experience recurrent headaches of over 3/10 intensity on a Numerical Pain Rating scale (NPS) lasting more than 4 hours in the preceding three months, be judged as having Migraine headache without aura according to International Headache Society Criteria scoring 14 or above on the Hamilton Rating Scale of Depression (HRSD), report average daily muscle pain intensity and joint pain at greater-than-3 levels on an NPS 0-10 rating system, and have served for 30 consecutive days in the Persian Gulf War region between August"
Are participants aged 55 and over being sought out for this research?
"This clinical trial mandates that patients must be aged 18 or above, but cannot exceed the age of 65."
What is the current tally of participants in this experiment?
"Affirmative. According to clinicaltrials.gov, this health trial is in the process of enlisting participants and was initially uploaded on October 1st 2019; subsequently updated February 4th 2022. The research project seeks 80 individuals across 3 medical facilities."
Is it possible to register for this clinical trial at present?
"Affirmative. According to clinicaltrials.gov, this medical research is currently enrolling participants which started on October 1st 2019 and has since been revised on February 4th 2022. Presently the trial requires 80 patients that will be sourced from three different sites."
Share this study with friends
Copy Link
Messenger